Epstein-Barr virus and Hodgkin lymphoma in Jordan. 2014

Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
Department of Pathology, King Hussein Cancer Center, Amman, Jordan. Electronic address: msughayer@khcc.jo.

OBJECTIVE This study aims to examine the possible association of Epstein-Barr virus (EBV) in Classical Hodgkin lymphoma (cHL) and to shed light on the epidemiology of Hodgkin lymphoma (HL) in Jordan. METHODS We examined 100 consecutive cases of HL for the presence of EBV in tumor cells by immunohistochemistry for latent membrane protein-1 (LMP-1). We collected patient data on age, sex and histologic subtype. We reviewed the pathological findings in each case and confirmed diagnosis. RESULTS Nodular lymphocyte predominant HL was diagnosed in 6% of the cases and these were negative for EBV LMP-1. Of the 94 cases of cHL, 65% were males, the most common subtype was nodular sclerosis (NS), representing 70% of the cases, and 45.7% of cHL (43% of all HL) cases were positive for EBV LMP-1. The positive cases were significantly related to age: ⩽15 years and >51 years (p: 0.009 and 0.014 respectively), male gender (p: 0.03) and mixed cellularity (MC) subtype (p: <0.0001). In line with other developing countries, there also appears to be a trend towards a decreasing association of EBV with cHL and a subtype switch from MC to NS in Jordan. CONCLUSIONS The epidemiology of HL in Jordan and some developing countries is approaching that of developed countries.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007597 Jordan A country in the MIDDLE EAST, northwest of Saudi Arabia, between Israel and Iraq. The capital is Amman.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D055815 Young Adult A person between 19 and 24 years of age. Adult, Young,Adults, Young,Young Adults

Related Publications

Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
March 2004, Southern medical journal,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
January 2007, Hematology. American Society of Hematology. Education Program,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
May 2018, Cancers,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
November 2022, The Journal of dermatology,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
December 2014, Chinese journal of cancer,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
January 2016, Journal of Ayub Medical College, Abbottabad : JAMC,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
May 1996, Journal of pediatric hematology/oncology,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
August 2014, Annals of diagnostic pathology,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
July 2022, Biomedicines,
Maher A Sughayer, and Hussam A Haddad, and Rana M Al-Yousef, and Mohammed El-Khateeb, and Hanood Abu-Rass
December 2022, International journal of molecular sciences,
Copied contents to your clipboard!